CRISPR Therapeutics (NASDAQ:CRSP) Hits New 12-Month High Following Insider Buying Activity

Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) hit a new 52-week high on Friday after an insider bought additional shares in the company. The company traded as high as $66.49 and last traded at $62.66, with a volume of 2037492 shares trading…

Read Full Article →